Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
  • Published Date:

    December 13 2019

  • Source:
    Influenza Other Respir Viruses. 14(2):237-243
  • Language:
    English
Filetype[PDF-304.04 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 589.00 KB]
    Personal Author:
    Petrie, Joshua G.; Martin, Emily T.; Truscon, Rachel; Johnson, Emileigh; Cheng, Caroline K.; McSpadden, E.J.; Malosh, Ryan E.; Lauring, Adam S.; Lamerato, Lois E.; Eichelberger, Maryna C.; Ferdinands, Jill M.; Monto, Arnold S.;
    Published Date:
    February 07 2019
    Source:
    Vaccine. 37(10):1284-1292
    Description:
    Background:Influenza vaccines are important for prevention of influenza-associated hospitalization. However, the effectiveness of influenza vaccines can vary by year and influenza type and subtype and mechanisms underlying this variation are incomple...
    File Type:
    Filetype[PDF - 589.00 KB]
  2. Filetype[PDF - 783.36 KB]
    Personal Author:
    Wesley, Meredith G.; Soto, Giselle; Arriola, Carmen Sofia; Gonzales, Miriam; Newes‐Adeyi, Gabriella; Romero, Candice; Veguilla, Vic; Levine, Min Z.; Silva, Maria; Ferdinands, Jill M.; Dawood, Fatimah S.; Reynolds, Sue B.; Hirsch, Avital; Katz, Mark; Matos, Eduardo; Ticona, Eduardo; Castro, Juan; Castillo, Maria; Bravo, Eduar; Cheung, Angela; Phadnis, Rachel; Martin, Emily Toth; Tinoco, Yeny; Neyra Quijandria, Joan Manuel; Azziz‐Baumgartner, Eduardo; Thompson, Mark G.;
    Corporate Authors:
    VIP Cohort Study Working Group
    Published Date:
    April 05 2020
    Source:
    Influenza Other Respir Viruses. 14(4):391-402
    Description:
    BackgroundThe Estudio Vacuna de Influenza Peru (VIP) cohort aims to describe the frequency of influenza virus infection, identify predictors of vaccine acceptance, examine the effects of repeated influenza vaccination on immunogenicity, and evaluate ...
    File Type:
    Filetype[PDF - 783.36 KB]
  3. Filetype[PDF - 103.31 KB]
    Personal Author:
    Thomas, Paul G.; Keating, Rachael; Hulse-Post, Diane J.; Doherty, Peter C.;
    Published Date:
    Jan 2006
    Source:
    Emerg Infect Dis. 12(1):48-54.
    Description:
    Current vaccine strategies against influenza focus on generating robust antibody responses. Because of the high degree of antigenic drift among circulating influenza strains over the course of a year, vaccine strains must be reformulated specifically...
    File Type:
    Filetype[PDF - 103.31 KB]
  4. Filetype[PDF - 508.11 KB]
    Personal Author:
    Harris, Vanessa C.; Armah, George; Fuentes, Susana; Korpela, Katri E.; Parashar, Umesh; Victor, John C.; Tate, Jacqueline; de Weerth, Carolina; Giaquinto, Carlo; Wiersinga, Willem Joost; Lewis, Kristen D. C.; de Vos, Willem M.;
    Published Date:
    Oct 31 2016
    Source:
    J Infect Dis. 2016; 215(1):34-41.
    Description:
     Rotavirus (RV) is the leading cause of diarrhea-related death in children worldwide and 95% of RV-associated deaths occur in Africa and Asia where RV vaccines (RVVs) have lower efficacy. We hypothesize that differences in intestinal microbiome com...
    File Type:
    Filetype[PDF - 508.11 KB]
  5. Filetype[PDF - 1.44 MB]
    Personal Author:
    Brickley, Elizabeth B; Strauch, Carolyn B; Wieland-Alter, Wendy F; Connor, Ruth I; Lin, Shu; Weiner, Joshua A; Ackerman, Margaret E; Arita, Minetaro; Oberste, M Steven; Weldon, William C; Sáez-Llorens, Xavier; Bandyopadhyay, Ananda S; Wright, Peter F;
    Published Date:
    Jan 17 2018
    Source:
    J Infect Dis. 2018; 217(3):371-380.
    Description:
    BackgroundThe impact of inactivated polio vaccines (IPVs) on intestinal mucosal immune responses to live poliovirus is poorly understood.MethodsIn a 2014 phase 2 clinical trial, Panamanian infants were immunized at 6, 10, and 14 weeks of age with biv...
    File Type:
    Filetype[PDF - 1.44 MB]